Patterns of care for patients with chronic kidney disease in the united states: Dying for improvement

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 2, 2003, Pages

  Owen, William F ^a,b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; HEMOGLOBIN A1C; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONFERENCE PAPER; CONSULTATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH SURVEY; HEMATOCRIT; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTRAVASCULAR CATHETER; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAMMOGRAPHY; MEDICAL SPECIALIST; MORTALITY; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RECIPIENT; RISK ASSESSMENT; SURVIVAL RATE; TECHNIQUE; TREATMENT PLANNING; UNITED STATES; VASCULAR ACCESS;

EID: 0038205794     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. National Institute of Diabetes and Digestive and Kidney Diseases: Healthy People 2010: Chronic Kidney Disease, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000
2. U.S. Renal Data System: USRDS 2002 Annual Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
3. U.S Renal Data System: USRDS 1993 Annual Report, Bethesda, MD, 1993
4. U.S. Renal Data System: USRDS 1999-2002 Annual Reports: Atlas Of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999-2002
5. US Renal Data System: USRDS 1999 Annual Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999.
6. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US Population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32: 992-999, 1998
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in the Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annal Int Med 130: 461-470, 1999
8. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in non-diabetic Americans: Third National Health And Nutrition Examination Survey (NHANES III). J Am Soc Nephrol, in-press
9. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S242, 2002
10. Renal Physicians Association: Appropriate Preparation of the Patient for Renal Replacement Therapy: Clinical Practice Guideline No. 3, Rockville, MD, RPA 2002
11. National Center for Health Statistics: Third National Health and Nutrition Examination Survey, 1988-1994: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94 [CD-ROM, rev. Sept. 1997], Hyattsville, MD, Centers for Disease Control and Prevention, 1996
12. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161: 1207-1216, 2001
13. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J, for the National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group: Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 36: 646-661, 2000
14. McClellan WM, Knight DF, Karp H, Brown WW: Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am J Kidney Dis 29: 368-375, 1997
15. Kissmeyer L, Kong C, Unwin RJ, Woolfson RG, Neild GH: Community nephrology: Audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplant 14: 2150-2155, 1999
16. NKF-DOQI: Clinical practice guidelines for the treatment of anemia of chronic renal failure: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30: S192-S240, 1997
17. Fink J, Blahut S, Reddy M, Light P: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348-355, 2001
18. Collins AJ, Li S, St Peter W, Ebben J, Roberts T, Ma JZ Manning W: Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12: 2465-2473, 2001
19. Collins AJ, Li S, Ebben J, Ma JZ, Manning W: Hematocrit levels and associated Medicare expenditures. Am J Kidney Dis 36: 282-293, 2000
20. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10: 610-619, 1999
21. Owen WF, Szczech L, Johnson C, Frankenfield D: National perspective on iron as a clinical performance measure of maintenance hemodialysis patients. Am J Kidney Dis 34: S1-S9, 1999
22. Coladonato JA, Frankenfield DL, Reddan D, Klassen P, Szczech L, Johnson CA, Owen WF: Trends in anemia management among U.S. hemodialysis patients. J Am Soc Nephrol 13: 1288-1295, 2002
23. NKF-DOQI: Clinical practice guidelines for vascular access: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 30: S150-191, 1997
24. NKF-K/DOQI: Clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 37: S137-S181, 2001
25. Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladanato J, Rocco M, Owen WF: National profile of practices patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol, in press
26. Woods JD, Turenne MN, Strawderman RL, Young EW, Hirth RA, Port FK, Held PJ: Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis 30: 50-57, 1997
27. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn R: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Int Med. 162: 2002-2006, 2002
28. Avorn J, Winkelmayer W, Bohn RL, Levin R, Glynn RJ, Levy E, Owen WF: Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol 55: 711-716, 2002
29. Klassen PS, Reddan DN, Schwab S, Szczech LA, Coladonato JA, Frankenfield DL, Owen WF: Association between vascular access types and hemodialysis patient mortality. JAMA, in review.
30. Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J: Late referral and modality choice in end-stage renal disease. Kidney Int 60: 1547-1554, 2001
31. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
32. Epstein AM, Ayanian JZ, Keogh JH, Noonan SJ, Armistead N, Cleary PD, Weissman JS, David-Kasdan JA, Carlson D, Fuller J, Marsh D, Conti RM: Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med 343: 1537-1544, 2000
33. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344: 726-731, 2001
34. Rasgon S, Schwankovsky L, James-Rogers A, Widrow L, Glick J, Butts E: An intervention for employment maintenance among blue-collar workers with end-stage renal disease. Am J Kid Dis 22: 403-412, 1993
35. Winkelmayer WC, Owen W, Glynn RJ, Levin R, Avorn J: Preventive health care measures before and after start of renal replacement therapy. J Gen Int Med, in-press
36. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn R: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Int Med 162: 2002-2006, 2002
37. Kinchen KS, Sadler S, Fink N, Brokmeyer R, Klag MJ, Levey AS, Powe NR: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Int Med 137: 479-486, 2002
38. Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J: Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis 38: 1178-1184, 2001